Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr;19(4):223-227.
doi: 10.1016/j.reumae.2022.02.008.

Lupus anticoagulant-hypoprothrombinemia syndrome: A cerebral bleeding case report as systemic lupus erythematosus debut

Affiliations
Free article
Case Reports

Lupus anticoagulant-hypoprothrombinemia syndrome: A cerebral bleeding case report as systemic lupus erythematosus debut

Miriam Lopez Pérez et al. Reumatol Clin (Engl Ed). 2023 Apr.
Free article

Abstract

Lupus anticoagulant-hypoprothrombinaemia syndrome (LAHPS) is a rare disorder caused by the presence of lupus anticoagulant (LA) and acquired prothrombin deficiency, which may present with severe haemorrhagic manifestations. LAHPS is usually associated with systemic lupus erythematosus (SLE), or infections and it is more frequent in the paediatric population and female gender. We describe a 42-year-old man with thrombotic antiphospholipid syndrome (APS) on chronic anticoagulation treatment with acenocoumarol who presented with spontaneous intracranial bleeding, prolongation of prothrombin time (PT), activated partial thromboplastin time (APTT) and low factor II levels (after optimal anticoagulation reversal) as a debut of SLE.

Keywords: Adult; Adulto; Hipoprotrombinemia; Hypoprothrombinaemia; Inhibidor de la coagulación lúpica; Lupus anticoagulant-hypoprothrombinaemia syndrome; Lupus coagulation inhibitor; Lupus eritematoso sistémico; Systemic lupus erythematosus; Síndrome de anticoagulante lúpico-hipoprotrombinemia.

PubMed Disclaimer

Publication types